<DOC>
	<DOCNO>NCT00001371</DOCNO>
	<brief_summary>This study pilot trial design evaluate topical antiflammin-2 , phospholipase A2 ( PLA2 ) inhibitor , treatment chronic plaque psoriasis . Antiflammin-2 ointment base , vehicle alone apply four time per day single plaque randomize , double-blinded fashion .</brief_summary>
	<brief_title>A Pilot Study Topical Antiflammin-2 Psoriasis</brief_title>
	<detailed_description>This study pilot trial design evaluate topical antiflammin-2 , phospholipase A2 ( PLA2 ) inhibitor , treatment chronic plaque psoriasis . Antiflammin-2 ointment base , vehicle alone apply four time per day single plaque randomize , double-blinded fashion .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Patients must age 18 old . Patients male female must use contraception childbearing age . No men woman actively attempt conceive child time drug test . No pregnant nursing woman . Patients must otherwise healthy , immunocompetent , ambulatory patient psoriasis 5 percent body surface area involve disease localize disable psoriasis . Have fail one prior topical treatment regimen include topical cortiscosteroids , coat tar preparation , ultraviolet light . An ambulatory performance status 0,1,2 ( ECOG Scale ) . Ability participate patient study provide inform consent . Creatinine le 2.0 mg/100ml . Bilirubin le equal 1.5 mg/100ml ; prothrombin time le equal 1.3 time control . WBC great 3000/mm ( 3 ) , granulocytes great 1500/mm ( 3 ) , platelets great 100,000/mm ( 3 ) . No clinically significant cardiac disease . No patient previously document serious infectious disease pneumocystis pneumonia , mycobacterium avium infection , etc . would suggest clinically evident immunodeficiency . No systemic treatment psoriasis ( methotrexate , PUVA , UVB , cyclosporine , etc . ) topical treatment ( corticosteroid , tar , anthralin , etc . ) four week prior study entry , topical treatment two week prior study entry .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 1999</verification_date>
	<keyword>Inflammation</keyword>
	<keyword>Lipocortin</keyword>
	<keyword>Phospholipase A-2</keyword>
	<keyword>Skin</keyword>
	<keyword>Uteroglobin</keyword>
	<keyword>Psoriasis</keyword>
</DOC>